Evidence map›Paper›PMID 40610910›Full record

ArticleBMC public health2025

Effectiveness of pay it forward intervention compared to free and user-paid vaccinations on seasonal influenza vaccination among older adults across seven cities in China: study protocol of a three-arm cluster randomized controlled trial.

Qing-Qing Li, Zizhen Huang, Jiangyun Chen, Junjie Wang, Duqiao Li, Xiaoshan Chen, Qing Zhao, Siyuan Liu, Wenjun He, Huanyuan Luo and 8 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Qing-Qing Li *Acacia Lab for Implementation Science, Institute for Global Health, Dermatology Hospital of Southern Medical University, Guangzhou, China.
Zizhen Huang *Acacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Jiangyun ChenAcacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Junjie WangSchool of Foreign Studies, Southern Medical University, Guangzhou, China.
Duqiao LiAcacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Xiaoshan ChenAcacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Qing ZhaoAcacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Siyuan LiuAcacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Wenjun HeAcacia Lab for Implementation Science, Institute for Global Health, Dermatology Hospital of Southern Medical University, Guangzhou, China.
Huanyuan LuoAcacia Lab for Implementation Science, Institute for Global Health, Dermatology Hospital of Southern Medical University, Guangzhou, China.
Yuting WanAcacia Lab for Implementation Science, School of Health Management, Southern Medical University, Guangzhou, China.
Guangyu TongDepartment of Internal Medicine, Yale School of Medicine, New Haven, USA.
Dexing ZhangJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Sha Tin, Hong Kong, China.
Yiyuan CaiAcacia Lab for Primary Healthcare, Department of epidemiology and health statistics, School of Public Health, Guizhou Medical University, Gui'an, China.
Huijuan LiangSchool of Health Management, Inner Mongolia Medical University, Hohhot, China.
Dan WuDepartment of Social Medicine and Health Education, School of Public Health, Nanjing Medical University, Nanjing, China.
David BishaiSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong,, Hong Kong Special Administrative Region, Hong Kong, China.
Dong Roman XuAcacia Lab for Implementation Science, School of Health Management and Dermatology Hospital, Southern Medical University, Guangzhou, China. romanxu@i.smu.edu.cn.

Funding

China Postdoctoral Science Foundation 2023M741549Swiss Agency for Development and Cooperation 81067392
6 · The paper itself

Abstract

backgroundSeasonal influenza poses an enormous burden worldwide, with older adults facing preventable morbidity and mortality. However, seasonal influenza vaccination coverage is poor among older populations in China. Pay-it-forward (giving a person a free vaccine and an opportunity to donate to support others) and financial incentives (e.g. free vaccination) could be effective in improving influenza vaccine uptake, but there are no prospective comparisons of these two strategies among older adults. The proposed study aims to compare the effectiveness of the pay-it-forward strategy in increasing influenza vaccination against free vaccination and user-paid vaccination among older adults in China.

methodsThis study is a three-arm cluster randomized controlled trial, which will be conducted in 21 community health centers across seven cities in China. A total of 1113 eligible older adults aged ≥ 60 years will be recruited. Three clusters in each city (total of 21 clusters in 7 cities) will be randomized into three arms in a 1:1:1 ratio, including (1) pay-it-forward arm: free vaccination and participants donate any amount of money to help other people; (2) free vaccination arm; and (3) standard-of-care arm (user-paid vaccination). The primary outcome is influenza vaccination verified by administrative records. Secondary outcomes include willingness to be vaccinated, willingness to donate, amount of donation, and incremental cost-effectiveness ratio. The primary outcome will be calculated for each arm and compared using one-way variance analysis. DISCUSSION: This study will examine the effectiveness of pay-it-forward strategy in comparison to the free vaccination and user-paid vaccination in improving influenza vaccination among older adults. Our findings will provide insights into better strategies for enhancing influenza vaccination, and support evidence-based policy decisions for promoting influenza vaccination.

trial registrationChinese Clinical Trial Registry (No. ChiCTR2400086840). Registered on 11 July 2024.

Indexed as

Influenza, HumanInfluenza VaccinesVaccinationAgedChinaCitiesFemaleHumansMaleMiddle AgedMotivationRandomized Controlled Trials as TopicSeasonsInfluenza VaccinesCluster randomized controlled trial (RCT)Free vaccinationInfluenza vaccineOlder adultsPay it forward

Identifiers

PMID40610910
PMCPMC12225192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.